ghk cu health risks GHK-Cu Peptide for Body Composition & Metabolism Exploring the beneficial effects of

Completed human trials establishing safety and efficacy would enable consideration for approval pathways

Protocol 1: standard longevity cycle Goal: General anti-aging and telomere maintenance Duration: 20 days active, then 4-6 months off Schedule: Days 1-20: 5 mg epitalon subcutaneously, once daily at bedtime Days 21-180: Off cycle, no epitalon Repeat cycle 1-2 times per year Reconstitution: 10 mg vial plus 2 mL bacteriostatic water equals 5 mg/mL

In the PEN form, the peptide is present as a pre-dissolved solution with a total content of 20 mg in the applicator

It is evident in whole-animal studies where the underlying cellular and molecular mechanisms are difficult to resolve, and it is often studied in isolated tissues where tolerance can be measured as a rightward shift in the dose-response curve that may also be associated with a reduction in the maximum response